Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seoul Court Overturns Health Ministry's 14-Percent Price Cut On Novartis' Glivec

This article was originally published in The Pink Sheet Daily

Executive Summary

The threatened price cut is suspended until the court battle is played out between Novartis and the ministry, the Administrative Court ruled.
Advertisement

Related Content

Roche Hits A Wall With Its Tarceva Patent Claims In India; Novartis Moves Supreme Court For Glivec Rights
Facing Calls For Compulsory Licensing, Roche To Provide Fuzeon In Korea Under Compassionate Access Program
South Korea Govt Proposes “Refund System” To Keep MNC Drug Prices Up, Provide Access To Patients
South Korea Govt Proposes “Refund System” To Keep MNC Drug Prices Up, Provide Access To Patients

Topics

Advertisement
UsernamePublicRestriction

Register

PS069974

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel